Phase 1, Single and Multiple Doses Study of Sitaxentan in Japanese and Western Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions

Healthy

Interventions

DRUG

Sitaxentan sodium/Placebo

100 mg and 200 mg, tablet, single and multiple oral doses for 7 days

DRUG

Sitaxentan sodium/Placebo

100 mg and 200 mg, tablet, single oral dose

Trial Locations (1)

Pfizer Investigational Site, Glendale